INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming Deadlines
Pomerantz LLP announces that a class action lawsuit has been filed against NowRx, Inc. (“NowRx” or the “Company”). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. […]